Pharmacological inhibition of a protein reduces metastases in Ewing’s Sarcoma in vivo and in vitro models
The G9a enzyme increases the probability of developing metastases in these bone or soft tissue neoplasms. However, treatment with its inhibitor (BIX01294) could improve the control of metastasis in patients.